Abingdon Health (LON:ABDX) Hits New 52-Week High – What’s Next?

Abingdon Health Plc (LON:ABDX) reached a new 52-week high on Wednesday . The stock traded as high as GBX 13 and last traded at GBX 12.58, with a volume of 123163 shares. The stock had previously closed at GBX 12.25.

Abingdon Health Stock Up 2.0%

The firm has a 50 day simple moving average of GBX 10.22 and a two-hundred day simple moving average of GBX 7.94. The company has a quick ratio of 1.96, a current ratio of 1.91 and a debt-to-equity ratio of 15.05. The stock has a market capitalization of £32.64 million, a P/E ratio of -16.05 and a beta of 0.12.

Abingdon Health (LON:ABDX) last released its earnings results on Tuesday, March 17th. The company reported GBX (0.43) earnings per share for the quarter. Abingdon Health had a negative return on equity of 55.91% and a negative net margin of 33.88%.

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.